By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for “BOTOX PRACTICE SOLUTIONS” by Susan J. Hinchey, representing Allergan. This application was made available to the public on June 30, 2014 (see also Pharmaceutical Companies).
The serial number for this application is 85894423.
The international trademark goods and services class code for this trademark application is 035.
As submitted by the applicant, this trademark application relates to the following goods and services: Providing practice management support services to individual physicians or small group practices specific to their onabotulinum toxin clinical/operational processes to enhance access to onabotulinum toxin therapy for appropriate patients and help to further improve patient outcomes and satisfaction.
The owner/registrar information for this application is: Susan J. Hinchey, Allergan, 2525 Dupont Dr, Irvine, CA 92612-1599.
Keywords for this news article include: Pharmaceutical Companies, Allergan, Trademarks.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Allergan’s Trademark Application for “BOTOX PRACTICE SOLUTIONS” Filed
By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for
- 1 min Read
- 07.9.2014
Why have three of the most successful men in Silicon Valley decided to branch out from computing and into nuclear energy?
The Fed model compares the return profile of stocks and US government bonds.
Why distillate crack spreads will likely experience more volatility.
When people talk about interest rates, real estate prices, and cyclical and secular trends, there’s one piece of context they tend not to mention.
The saying that there is no such thing as a free lunch is very much true for Robinhood.
Another Black Swan event is taking place right now. And it’s likely to have a similar effect on uranium prices.
